FDA Panel Backs At-Home HIV Test

<p>TUESDAY, May 15 (HealthDay News)
A U.S. Food and Drug Administration advisory row endorsed Tuesday
approval of a initial HIV exam that would give people a formula in the
privacy of their possess home.
The 17 row members were unanimous in voting that a advantages of the
test were larger than any probable risks. The exam kit, famous as
Oraquick, detects a participation of HIV a pathogen that causes AIDS
within 20 minutes, a Associated Press reported.
If a FDA heeds a recommendation of a advisory panel, a decision
could pave a approach toward a new epoch in HIV testing. The group typically
follows a recommendations of a advisory groups.
OraSure Technologies Inc., that creates a over-the-counter test,
already sells a chronicle of it to doctors and other health professionals.
Studies have shown a exam was reduction accurate when used by consumers, but
the panelists pronounced Tuesday that a advantages of expanding HIV testing
outweigh a tiny dump in exam accuracy, according to...